Consumer Reduced-Risk Nicotine

​Current products in the reduced-risk nicotine market apply heat to nicotine-based solutions to create aerosol. Published scientific studies have concluded that the heating of these solutions causes the formation and delivery of toxic byproducts and carcinogens similar to those caused by the smoking of cigarettes​.

We believe we have developed a technology platform to replace cigarettes and e-cigarettes:

  • The platform delivers aerosols with no heating or combustion and, therefore, no thermally generated toxic byproducts or carcinogens.
  • Our platform uses a new and highly advanced aerosol generation technology.
  • The technology generates aerosols comprised of extremely small droplet sizes (diameters of less than 1 µm), which are required for nonheated inhaled nicotine delivery.
  • Our product is capable of employing fingerprint authorization, which can help to prevent misuse of the device by underage and other unauthorized users.

Pneuma’s device produces aerosol without heating or combustion, eliminating thermally generated toxins and carcinogens found in both cigarettes and vapes. With technology that we believe can deliver inhaled nicotine without harming the user, our platform could rapidly gain a foothold in the global reduced-risk nicotine market, with the goal of ultimately replacing cigarettes and vapes.